» Articles » PMID: 35690508

Patient Satisfaction With Spinal Cord Stimulation and Dorsal Root Ganglion Stimulation for Chronic Intractable Pain: A Systematic Review and Meta-Analysis

Overview
Journal Neuromodulation
Publisher Elsevier
Date 2022 Jun 11
PMID 35690508
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: In the spinal cord stimulation (SCS) and dorsal root ganglion stimulation (DRG-S) literature, the typical primary outcome measure includes pain relief, whether numeric rating scale changes or percentage pain relief, and functional outcomes and patient satisfaction are included as secondary outcomes. This systematic review and meta-analysis aims to determine the rate of patient satisfaction with the use of SCS and DRG-S in the treatment of chronic intractable pain.

Materials And Methods: The study protocol was registered in the PROSPERO International prospective register of systematic reviews. We queried articles from multiple electronic data bases, including MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials data bases, and hand-searched reference lists of identified publications. All periods were included. Inclusion criteria encompassed randomized controlled trials (RCTs) and prospective observational studies that reported patient satisfaction in patients who underwent SCS or DRG-S. Bias evaluation for the included studies involved appropriate guidelines for each study design (Cochrane risk of bias tool for RCTs and Newcastle-Ottawa scale for observational studies).

Results: Our search strategy identified 242 unique citations, of which nine RCTs and 23 observational studies were included for analysis. Overall, 25 studies comprising 1355 participants were pooled in our quantitative analysis. The pooled proportion of patients who reported satisfaction from all studies was 82.2% (95% CI, 77.8%-86.2%). This finding had high statistical heterogeneity (I = 74.0%). Subgroup analysis did not reveal differences in satisfaction when studies were stratified based on study design (RCT or observational study) or follow-up period (six, 12, 24, and 36 months).

Conclusions: Our results show high levels of patient satisfaction across the SCS and DRG-S literature when these treatment modalities are used for chronic intractable pain, regardless of SCS programming algorithm. However, there is a scarcity of unbiased and/or non-industry-funded prospective studies in the neuromodulation field, and future efforts to expand this area of the SCS and DRG-S literature are greatly needed.

Citing Articles

Neuromodulation guide for the non-neuromodulator clinician: What it is and how it can benefit patients?.

Hoffmann C, Wang J, Ali R, DSouza R Biomol Biomed. 2024; 25(2):304-313.

PMID: 39132949 PMC: 11734817. DOI: 10.17305/bb.2024.10967.


Synergistic neuromodulation therapy for persistent spinal pain: a proof-of-concept trial on the use of spinal cord and dorsal root ganglion stimulation.

Fiedler A, Piedade G, Assumpcao de Monaco B, Taylor R, Williams M, Danny J Acta Neurol Belg. 2024; 124(5):1611-1616.

PMID: 38761329 DOI: 10.1007/s13760-024-02575-0.


Multidisciplinary strategies to treat painful mononeuropathies in the upper extremity: from lab to bedside.

Rijsdijk M, Tuffaha S, Coert J J Hand Surg Eur Vol. 2024; 49(6):792-801.

PMID: 38749904 PMC: 11143763. DOI: 10.1177/17531934241240389.


Precise management system for chronic intractable pain patients implanted with spinal cord stimulation based on a remote programming platform: study protocol for a randomized controlled trial (PreMaSy study).

Cheng Y, Xie D, Han Y, Guo S, Sun Z, Jing L Trials. 2023; 24(1):580.

PMID: 37691092 PMC: 10494385. DOI: 10.1186/s13063-023-07595-4.


Twiddler's syndrome after dorsal root ganglion stimulation: A case report.

Vanloon M, Raymaekers V, Meeuws S, Plazier M Heliyon. 2023; 9(8):e18365.

PMID: 37554798 PMC: 10404945. DOI: 10.1016/j.heliyon.2023.e18365.